Velcade and condition aggravated Patient Reports February 11, 2012

Velcade Side Effects Report #5531308-4
Velcade side effect was reported by a Physician from BELGIUM on Nov 13, 2007. Male patient was diagnosed with waldenstrom's macroglobulinaemia and was treated with Velcade. After drug was administered, patient experienced the following side effects: condition aggravated, emphysema, gastric haemorrhage, off label use. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient died.

Velcade Side Effects Report #5429387-8
Velcade side effect was reported by a Physician from FRANCE on Aug 13, 2007. Male patient, 59 years of age, weighting 143.3 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain upper, abdominal rigidity, anaemia, c-reactive protein increased, condition aggravated, cough, disease progression, epistaxis, febrile neutropenia. Velcade dosage: 2.76 MG, INTRAVENOUS. During the same period patient was treated with VINCRISTINE, DOXIL, CYCLOPHOSPHAMIDE, METHOTREXATE, PREDNISONE, BLEOMYCIN. Patient was hospitalized. Patient died on 06/03/2006.

Velcade Side Effects Report #5552343-6
Velcade side effect was reported by a Physician from FRANCE on Nov 27, 2007. Male patient, 59 years of age, weighting 65.00 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, cough, disease progression, febrile neutropenia, histiocytosis haematophagic, lymphoma , pulmonary haemorrhage, splenomegaly. Velcade dosage: 2.76 MG, INTRAVENOUS. During the same period patient was treated with VINCRISTINE, DOXIL, CYCLOPHOSPHAMIDE, METHOTREXATE, PREDNISONE, BLEOMYCIN. Patient was hospitalized. Patient died on 06/03/2006.

Velcade Side Effects Report #5746206-0
Velcade side effect was reported by a Physician from FRANCE on May 06, 2008. Male patient, 59 years of age, weighting 143.3 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, disease progression, febrile neutropenia, haemoglobin decreased, histiocytosis haematophagic, leukopenia, lymphoma , pulmonary haemorrhage. Velcade dosage: 2.76 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, METHOTREXATE, PREDNISONE, BLEOMYCIN SULPHATE, GRANOCYTE, ELDISINE. Patient was hospitalized. Patient died on 06/03/2006.


Velcade Side Effects Report #6065156-6
Velcade side effect was reported by a Physician from FRANCE on Jan 20, 2009. Male patient, 59 years of age, weighting 143.3 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, febrile neutropenia, histiocytosis haematophagic, lymphoma , pulmonary haemorrhage, renal failure acute, splenomegaly, thrombocytopenia. Velcade dosage: 2.76 MG UNK INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, METHOTREXATE, PREDNISONE, BLEOMYCIN SULPHATE, GRANOCYTE, ELDISINE. Patient was hospitalized. Patient died on 06/03/2006.

Velcade Side Effects Report #5042533-3
Velcade side effect was reported by a Physician from FRANCE on June 16, 2006. Male patient, 59 years of age, weighting 143.3 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain upper, condition aggravated, cough, febrile neutropenia, histiocytosis haematophagic, lymphoma , pulmonary haemorrhage, thrombocytopenia. Velcade dosage: 2.76 MG, INTRAVENOUS. During the same period patient was treated with VINCRISTINE, DOXIL, CYCLOPHOSPHAMIDE, METHOTREXATE, CORTAN, BLEOMYCIN. Patient was hospitalized. Patient died on 06/03/2006.

Velcade Side Effects Report #5967977-4
Velcade side effect was reported by a Physician from ITALY on Nov 12, 2008. Female patient, 50 years of age, was diagnosed with renal amyloidosis and was treated with Velcade. After drug was administered, patient experienced the following side effects: condition aggravated, hyponatraemic syndrome, muscle spasms, myalgia, renal failure. Velcade dosage: 1.8 MG, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #6016927-3
Velcade side effect was reported by a Health Professional from UNITED STATES on Dec 11, 2008. Male patient, 79 years of age, weighting 155.2 lb, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , chronic obstructive pulmonary disease, condition aggravated, fall , hypotension, lung infiltration, pleural effusion, pneumonia , pulmonary embolism . Velcade dosage: 2 MG/M2, INTRAVEOUS. During the same period patient was treated with ALIMTA, ESCITALOPRAM, POTASSIUM, MIDODRINE HYDROCHLORIDE, ACETAMINOPHEN AND OXYCODONE, SPIRIVA, VITAMINS, ASPIRIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5505002-X
Velcade side effect was reported by a Health Professional from UNITED STATES on Oct 31, 2007. Female patient, 62 years of age, weighting 107.4 lb, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: condition aggravated, disease progression, non-small cell lung cancer, pleural effusion, pneumonia , pulmonary oedema, renal failure acute, respiratory distress, troponin increased. Velcade dosage: 1.3 MG/M2 D1 AND 8 IV DRIP. Patient was hospitalized. Patient died on 10/20/2007.


Velcade Side Effects Report #5165150-3
Velcade side effect was reported by a Physician from FRANCE on Nov 13, 2006. Male patient, 71 years of age, weighting 218.3 lb, was diagnosed with myelodysplastic syndrome and was treated with Velcade. After drug was administered, patient experienced the following side effects: anuria, chest x-ray abnormal, condition aggravated, hilar lymphadenopathy, hypotension, ileus paralytic, intestinal obstruction, renal failure, respiratory disorder. Velcade dosage: 3.30 MG INTRAVENOUS. During the same period patient was treated with ARACYTINE. Patient was hospitalized. Patient died on 11/01/2006.

Velcade Side Effects Report #5348257-7
Velcade side effect was reported by a Physician from FRANCE on May 22, 2007. Female patient was diagnosed with myelodysplastic syndrome and was treated with Velcade. After drug was administered, patient experienced the following side effects: condition aggravated, haemorrhage, haemorrhoidal haemorrhage, mouth haemorrhage, petechiae, thrombocytopenia. Velcade dosage: 2.28 MG. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5869571-2
Velcade side effect was reported by a Health Professional from UNITED KINGDOM on Aug 18, 2008. Female patient, 84 years of age, weighting 160.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: condition aggravated, gastrointestinal haemorrhage, oesophagitis, renal failure chronic. Velcade dosage: 2.6 MG. During the same period patient was treated with DEXAMETHASONE, CALCICHEW, ACYCLOVIR, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5266999-9
Velcade side effect was reported by a Physician from UNITED STATES on Mar 01, 2007. Male patient, 82 years of age, weighting 173.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac failure congestive, chronic obstructive pulmonary disease, condition aggravated, hyperlipidaemia, mental status changes, multiple myeloma , pancytopenia. Velcade dosage: 1.90 MG,INTRAVENOUS. During the same period patient was treated with MELPHALAN, ASCORBIC ACID, LASIX, MICRO, DURAGESIC, ZOFRAN, ZOMETA, PROCRIT. Patient was hospitalized. Patient died on 11/18/2006.

Velcade Side Effects Report #5169057-7
Velcade side effect was reported by a Physician from UNITED STATES on Nov 21, 2006. Male patient, 82 years of age, weighting 173.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac failure congestive, chronic obstructive pulmonary disease, condition aggravated, hyperlipidaemia, mental status changes, multiple myeloma , pancytopenia, renal failure acute. Velcade dosage: 1.90 MG, INTRAVENOUS. During the same period patient was treated with MELPHALAN, ASCORBIC ACID. Patient was hospitalized. Patient died on 11/18/2006.


Velcade Side Effects Report #5226856-0
Velcade side effect was reported by a Physician from JAPAN on Jan 18, 2007. Male patient, 80 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood potassium decreased, condition aggravated, electrocardiogram qt prolonged, hypotension, no therapeutic response, pulmonary embolism , respiratory arrest, torsade de pointes, ventricular tachycardia. Velcade dosage: 1.30 MG/M2,. During the same period patient was treated with LAFUTIDINE, SELBEX, DIFLUCAN, ALENDRONATE, ROHYPNOL, BAKTAR, HEPARIN. Patient died on 01/08/2007.

Velcade Side Effects Report #5674060-4
Velcade side effect was reported by a Health Professional from COLOMBIA on Mar 04, 2008. Male patient, 80 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: condition aggravated, diabetes mellitus. Velcade dosage: 1.30 MG/M2. During the same period patient was treated with ZOMETA. Patient was hospitalized. Patient died on 02/27/2008.

Velcade Side Effects Report #5707892-4
Velcade side effect was reported by a Physician from JAPAN on Apr 03, 2008. Female patient, 80 years of age, weighting 74.96 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood lactate dehydrogenase increased, blood pressure decreased, blood uric acid increased, c-reactive protein increased, cardiac failure, condition aggravated, constipation , depressed level of consciousness. Velcade dosage: 1.40 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, FOSAMAX, ALDACTONE, DIFLUCAN, TENORMIN, ASPIRIN, SULFAMETHOXAZOLE AND TRIMETHOPRIM, PROTECADIN. Patient died on 10/24/2007.

Velcade Side Effects Report #5804269-8
Velcade side effect was reported by a Physician from PORTUGAL on June 25, 2008. Male patient, 80 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: condition aggravated, diarrhoea, enterocolitis haemorrhagic, hypokalaemia, hyponatraemia, lower gastrointestinal haemorrhage, nervous system disorder, pancytopenia, renal failure chronic. Velcade dosage: 1.3 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5817616-8
Velcade side effect was reported by a Physician from PORTUGAL on July 08, 2008. Male patient, 80 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: condition aggravated, diarrhoea, enterocolitis haemorrhagic, hypokalaemia, hyponatraemia, lower gastrointestinal haemorrhage, nervous system disorder, pallor, pancytopenia. Velcade dosage: 1.3 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #6103142-8
Velcade side effect was reported by a Physician from PORTUGAL on Feb 19, 2009. Male patient, 80 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: condition aggravated, enterocolitis haemorrhagic, hypokalaemia, hyponatraemia, lower gastrointestinal haemorrhage, pallor, pancytopenia, renal failure chronic, respiratory tract infection. Velcade dosage: 1.3 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4578402-2
Velcade side effect was reported by a Health Professional from on Jan 27, 2005. Female patient, 80 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: condition aggravated, conjunctivitis, neuropathy peripheral. Velcade dosage: unknown. During the same period patient was treated with COUMADIN. Patient recovered.

Velcade Side Effects Report #4673699-2
Velcade side effect was reported by a Health Professional from on May 06, 2005. Female patient, 80 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: condition aggravated, conjunctivitis, dialysis , neuropathy peripheral, pain , performance status decreased. Velcade dosage: unknown. During the same period patient was treated with COUMADIN, OXYCONTIN, REGLAN, NEPHRO, LEVOXYL, PROAMATINE. Patient recovered.

Velcade Side Effects Report #5536813-2
Velcade side effect was reported by a Physician from SPAIN on Nov 22, 2007. Male patient, 79 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: condition aggravated, thrombocythaemia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, OMEPRAZOLE, ACYCLOVIR, SEPTRA, HIDROXIL PREDNI, ARANESP. Patient recovered.

Velcade Side Effects Report #5669982-4
Velcade side effect was reported by a Physician from SPAIN on Mar 03, 2008. Male patient, 79 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: condition aggravated, thrombocythaemia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, OMEPRAZOLE, ACYCLOVIR, SEPTRA, HIDROXIL PREDNI, ARANESP. Patient recovered.


Velcade Side Effects Report #5671588-8
Velcade side effect was reported by a Physician from SPAIN on Mar 03, 2008. Male patient, 79 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: condition aggravated, thrombocythaemia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, OMEPRAZOLE, ACYCLOVIR, SEPTRA, HIDROXIL PREDNI, ARANSEP. Patient recovered.

Velcade Side Effects Report #5729645-3
Velcade side effect was reported by a Physician from JAPAN on Apr 24, 2008. Male patient, 79 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, condition aggravated, procedural complication. Velcade dosage: unknown. Patient died on 03/30/2008.

Velcade Side Effects Report #5261526-4
Velcade side effect was reported by a Physician from JAPAN on Feb 19, 2007. Male patient, 78 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, anorexia, aspergillosis, blood albumin decreased, blood bilirubin increased, blood urea increased, condition aggravated, dehydration, ecchymosis. Velcade dosage: 1.88 MG. During the same period patient was treated with DEXAMETHASONE, FAMOTIDINE, FLIVAS, CLINORIL, ALFAROL, METHYCOBAL, FOLIC ACID, CALCIUM LACTATE. Patient died on 02/18/2007.

Velcade Side Effects Report #5361069-3
Velcade side effect was reported by a Physician from UNITED STATES on May 31, 2007. Female patient, 78 years of age, weighting 172.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, brain natriuretic peptide increased, cardiac failure congestive, cardiotoxicity, compression fracture, condition aggravated, epistaxis, hypotension. Velcade dosage: 1.30 MG/M2, IV BOLUS. During the same period patient was treated with DOXIL, PALONOSETRON, DEXAMETHASONE, PROCHLORPERAZINE MALEATE, COMPAZINE, COUMADIN, ASPIRIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5382080-2
Velcade side effect was reported by a Physician from UNITED STATES on June 21, 2007. Female patient, 78 years of age, weighting 172.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, atelectasis, cardiac failure congestive, cardiotoxicity, compression fracture, condition aggravated, coronary artery disease , epistaxis. Velcade dosage: unknown. During the same period patient was treated with DOXIL, PALONOSETRON, DEXAMETHASONE, PROCHLORPERAZINE MALEATE, COMPAZINE. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #5145595-8
Velcade side effect was reported by a Physician from UNITED STATES on Oct 24, 2006. Female patient, 77 years of age, weighting 119.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal discomfort, aortic valve incompetence, asthenia, brain scan abnormal, cardiomegaly, cerebral atrophy, cerebral haematoma, condition aggravated, decreased appetite. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with ZOMETA, THALIDOMIDE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5203475-3
Velcade side effect was reported by a Physician from AUSTRALIA on Dec 27, 2006. Female patient, 76 years of age, weighting 143.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: arrhythmia supraventricular, atrial fibrillation , cardiac failure, condition aggravated, confusional state, constipation , diarrhoea, dyspnoea, fatigue. Velcade dosage: 2.20 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, MS CONTIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5222736-5
Velcade side effect was reported by a Physician from GERMANY on Jan 12, 2007. Female patient, 76 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: condition aggravated. Velcade dosage: unknown. Patient died on 11/12/2006.

Velcade Side Effects Report #4709485-4
Velcade side effect was reported by a Health Professional from UNITED STATES on June 17, 2005. Male patient, 76 years of age, weighting 208.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, blood pressure decreased, condition aggravated, dizziness , haematotoxicity, heart rate increased, thrombocytopenia. Velcade dosage: 2.80 MG, INTRAVENOUS. During the same period patient was treated with LEKOVIT CA, FOLIC ACID, COLACE, SENNA, VALTREX, OXYCODONE, PAXIL. Patient recovered.

Velcade Side Effects Report #5617255-8
Velcade side effect was reported by a Physician from JAPAN on Jan 23, 2008. Male patient, 75 years of age, weighting 127.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anorexia, antibody test positive, bronchiectasis, condition aggravated, constipation , diarrhoea, hypertension, interstitial lung disease, movement disorder . Velcade dosage: 2.20 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ALFAROL, PURSENNID, MAGNESIUM OXIDE, LANSOPRAZOLE, KYTRIL, POLYETHYLENE GLYCOL, LOPERAMIDE. Patient was hospitalized and became disabled. Patient recovered.


Velcade Side Effects Report #5641652-8
Velcade side effect was reported by a Physician from JAPAN on Feb 14, 2008. Male patient, 75 years of age, weighting 127.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anorexia, antibody test positive, condition aggravated, constipation , diarrhoea, hypertension, interstitial lung disease, neurogenic bladder, neuropathy peripheral. Velcade dosage: 2.20 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ALFAROL, PURSENNID, MAGNESIUM OXIDE, LANSOPRAZOLE, KYTRIL, POLYETHYLENE GLYCOL, LOPERAMIDE. Patient was hospitalized and became disabled. Patient recovered.

Velcade Side Effects Report #5663658-5
Velcade side effect was reported by a Physician from JAPAN on Feb 26, 2008. Male patient, 75 years of age, weighting 127.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anorexia, antibody test positive, body temperature decreased, bronchopneumonia, condition aggravated, constipation , diarrhoea, hypertension, hypoaesthesia. Velcade dosage: 2.20 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ALFAROL, PURSENNID, MAGNESIUM OXIDE, LANSOPRAZOLE, KYTRIL, POLYETHYLENE GLYCOL, LOPERAMIDE. Patient was hospitalized and became disabled. Patient recovered.

Velcade Side Effects Report #4907779-0
Velcade side effect was reported by a Health Professional from UNITED KINGDOM on Jan 24, 2006. Female patient, 75 years of age, weighting 139.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, atrial fibrillation , cardiac enzymes increased, condition aggravated, diarrhoea, fluid overload, haematemesis, hypothermia , melaena. Velcade dosage: 2.10 MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with CLODRONATE DI, ALLOPURINOL, AMLODIPINE, LOPERAMIDE, METRONIDAZOLE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5330084-8
Velcade side effect was reported by a Consumer or non-health professional from FRANCE on May 02, 2007. Male patient, 74 years of age, weighting 165.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute leukaemia, chromosome analysis abnormal, condition aggravated, multiple myeloma , myelocytosis, neurotoxicity. Velcade dosage: 9.60 MG, INTRAVENOUS. During the same period patient was treated with ALKERAN, CYCLOPHOSPHAMIDE, THALIDOMIDE. Patient recovered.

Velcade Side Effects Report #5341867-2
Velcade side effect was reported by a Consumer or non-health professional from FRANCE on May 16, 2007. Male patient, 74 years of age, weighting 165.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: chromosome analysis abnormal, condition aggravated, multiple myeloma , myeloid leukaemia, neurotoxicity. Velcade dosage: 9.60 MG, UNK, INTRAVENOUS. During the same period patient was treated with ALKERAN, CYCLOPHOSPHAMIDE, THALIDOMIDE. Patient recovered.


Velcade Side Effects Report #5292555-2
Velcade side effect was reported by a Physician from KOREA, REPUBLIC OF on Mar 23, 2007. Female patient, 73 years of age, weighting 114.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute myocardial infarction, condition aggravated, hypertension, multiple myeloma , thrombocytopenia. Velcade dosage: 1.30 MG/M2, UNK, INTRAVENOUS. During the same period patient was treated with GATIFLOXACIN, PAMIDRONATE DI, MEFENAMIC ACID. Patient died on 01/29/2007.

Velcade Side Effects Report #5489258-8
Velcade side effect was reported by a Health Professional from UNITED STATES on Oct 08, 2007. Male patient, 73 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: aortic stenosis, cardiac failure, condition aggravated, pulmonary hypertension . Velcade dosage: unknown. During the same period patient was treated with COUMADIN, WHEAT, IRON, TIAZAC. Patient recovered.

Velcade Side Effects Report #6094783-5
Velcade side effect was reported by a Physician from UNITED STATES on Feb 17, 2009. Male patient, 73 years of age, weighting 231.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: activities of daily living impaired, blood creatinine increased, blood urea increased, bronchitis , cellulitis , chronic obstructive pulmonary disease, coagulopathy, condition aggravated, cough. Velcade dosage: 2.77 MG, IV BOLUS. During the same period patient was treated with DEXAMETHASONE, POTASSIUM CHLORIDE, COUMADIN, FUROSEMIDE, ALLOPURINOL, HYDROCHLOROTHIAZIDE, GLUCOPHAGE, COREG. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4701548-2
Velcade side effect was reported by a Physician from on June 13, 2005. Male patient, 73 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, anuria, bronchopneumonia, cardiac disorder, condition aggravated, gastrointestinal haemorrhage, hyperkalaemia, hypoglycaemia, hypovolaemic shock. Velcade dosage: 2.10 MG QD INTRAVENOUS. During the same period patient was treated with ALLOPURINOL, ITRACONAZOLE, COTRIMOXAZOL, CLICLAZIDE, METHYLPREDNISOLONE, PANTOPRAZOLE, AMPICILLIN. Patient died on 05/16/2005.

Velcade Side Effects Report #5226888-2
Velcade side effect was reported by a Physician from JAPAN on Jan 15, 2007. Male patient, 72 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cardiac failure, cardiovascular insufficiency, cerebral infarction, condition aggravated, dehydration, depressed level of consciousness, disease recurrence, hypercalcaemia, interstitial lung disease. Velcade dosage: 1.30 MG/M2,. During the same period patient was treated with DEXAMETHASONE, ISOSORBIDE DINITRATE, FAMOTIDINE, BAKTAR, ALLOPURINOL, BICARBONATE, LASIX. Patient died on 01/14/2007.

Velcade Side Effects Report #5599225-1
Velcade side effect was reported by a Physician from UNITED STATES on Jan 10, 2008. Female patient, 72 years of age, weighting 117.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: clostridium difficile colitis, condition aggravated, neuropathy peripheral, poliomyelitis, rotavirus infection , virus stool test positive. Velcade dosage: 1.00 MG/M2,. During the same period patient was treated with MELPHALAN, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5714120-2
Velcade side effect was reported by a Physician from JAPAN on Apr 08, 2008. Female patient, 72 years of age, weighting 108.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, cardiac failure congestive, cardiogenic shock, condition aggravated, diarrhoea, hyperglycaemia, hypoaesthesia, no therapeutic response. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DECADRON. Patient died on 03/21/2008.

Velcade Side Effects Report #6058152-6
Velcade side effect was reported by a Pharmacist from FRANCE on Dec 12, 2008. Male patient, 72 years of age, weighting 147.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cataract , condition aggravated. Velcade dosage: 1 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ALKERAN. Patient recovered.

Velcade Side Effects Report #4878071-8
Velcade side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Dec 26, 2005. Male patient, 72 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase abnormal, aspartate aminotransferase increased, blood albumin decreased, condition aggravated, haemodialysis, haemoglobin abnormal, hypotension, labile blood pressure, platelet disorder. Velcade dosage: 1.30 MG/M2, 2/WEEK, INTRAVENOUS. During the same period patient was treated with BETAMETHASONE. Patient was hospitalized. Patient died on 08/01/2003.

Velcade Side Effects Report #5301270-8
Velcade side effect was reported by a Physician from BRAZIL on Mar 30, 2007. Female patient, 71 years of age, weighting 156.5 lb, was diagnosed with multiple myeloma , bone pain and was treated with Velcade. After drug was administered, patient experienced the following side effects: anorexia, condition aggravated, neuropathy, spinal cord compression, thrombocytopenia, weight decreased. Velcade dosage: 1.30 MG/M2, UNK, INTRAVENOUS. During the same period patient was treated with TYLEX, CODEINE SUL, ACETAMINOPHEN, TRAMADOL. Patient recovered.


Velcade Side Effects Report #5332903-8
Velcade side effect was reported by a Physician from JAPAN on May 08, 2007. Male patient, 71 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: basophil count decreased, blood alkaline phosphatase decreased, blood glucose increased, blood lactate dehydrogenase increased, blood urea increased, blood uric acid increased, computerised tomogram thorax abnormal, condition aggravated, febrile neutropenia. Velcade dosage: 1.00 MG/M2, INTRAVENOUS. During the same period patient was treated with ZOMETA, BICARBONATE, NEUTROGIN, AMIKACIN SULPHATE, LASIX, VORICONAZOLE, RABEPRAZOLE, ENALAPRIL MALEATE. Patient died on 05/07/2007.

Velcade Side Effects Report #5411164-5
Velcade side effect was reported by a Physician from JAPAN on July 27, 2007. Female patient, 71 years of age, weighting 79.37 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: condition aggravated, pleural effusion. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. Patient recovered.

Velcade Side Effects Report #6053881-2
Velcade side effect was reported by a Physician from JAPAN on Jan 15, 2009. Female patient, 71 years of age, weighting 79.37 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, arteriosclerosis coronary artery, blood creatinine increased, blood lactate dehydrogenase increased, blood sodium decreased, blood urea increased, bronchopneumonia, condition aggravated, disseminated intravascular coagulation. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with LASIX, OMEPRAZON, ALLOPURINOL, SELBEX, ZOLPIDEM TARTRATE, VERAPAMIL HYDROCHLORIDE, TAMBOCOR, THALIDOMIDE. Patient was hospitalized. Patient died.

Velcade Side Effects Report #5274576-9
Velcade side effect was reported by a Physician from KOREA, REPUBLIC OF on Mar 16, 2007. Male patient, 69 years of age, weighting 148.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: condition aggravated, dyspnoea, productive cough, respiratory arrest. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE. Patient died on 02/12/2007.

Velcade Side Effects Report #5105272-6
Velcade side effect was reported by a Health Professional from UNITED STATES on Aug 25, 2006. Female patient, 69 years of age, weighting 210.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain , agitation, arrhythmia , bradycardia, cardiac failure congestive, chronic obstructive pulmonary disease, condition aggravated, confusional state. Velcade dosage: 1.00 MG/M2, INTRAVENOUS; 1015 MG/M2, INTRAVENOUS. During the same period patient was treated with SYNTHROID, DIOVAN, ALTACE, CYANOCOBALAMIN, COUMADIN, PROTONIX, MECLIZINE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4818892-0
Velcade side effect was reported by a Health Professional from POLAND on Oct 17, 2005. Female patient, 69 years of age, weighting 154.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cerebral ischaemia, condition aggravated, coordination abnormal, depressed level of consciousness, diarrhoea, hypertension, vomiting. Velcade dosage: 1.30 MG/M2, 2/WEEK, INTRAVENOUS. During the same period patient was treated with DOXIL, CAPTOPRIL, LEVOTHYROXINE, INDAPARMIDE, SOTALOL, TIANEPTINE, KETOPROFEN, RANITIDINE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5164852-2
Velcade side effect was reported by a Physician from PORTUGAL on Nov 13, 2006. Female patient, 68 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: condition aggravated, infection , paraesthesia, therapeutic response decreased. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, DEXAMETHASONE, ASPIRIN. Patient recovered.

Velcade Side Effects Report #5170353-8
Velcade side effect was reported by a Physician from CHINA on Nov 21, 2006. Female patient, 68 years of age, weighting 112.4 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: condition aggravated, metabolic acidosis, renal failure chronic, renal tubular acidosis. Velcade dosage: 1.70 MG,. During the same period patient was treated with MYLERAN, PREDNISONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5645016-2
Velcade side effect was reported by a Health Professional from UNITED STATES on Feb 15, 2008. Female patient, 68 years of age, weighting 209.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: chronic obstructive pulmonary disease, condition aggravated, constipation , syncope. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ADVAIR DISKUS, METOPROLOL TARTRATE, PROZAC, PROTONIX, DILTIAZEM, CALCITROL, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5748492-X
Velcade side effect was reported by a Health Professional from UNITED STATES on May 08, 2008. Female patient, 68 years of age, weighting 209.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: apnoea, blood pressure increased, chronic obstructive pulmonary disease, condition aggravated, constipation , haemoglobin decreased, neuropathy peripheral, oxygen saturation decreased, respiratory rate increased. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ADVAIR DISKUS, METORPOLOL, PROZAC, PROTONIX, DILTIAZEM, CALCITROL, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #4943611-7
Velcade side effect was reported by a Physician from JAPAN on Feb 14, 2006. Female patient, 68 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, cardiac failure congestive, cardiomegaly, condition aggravated, disease progression, lung disorder, lung infiltration, oliguria, renal impairment. Velcade dosage: unknown. During the same period patient was treated with BISPHOSPHONATES, DEXAMETHASONE. Patient died on 11/12/2004.

Velcade Side Effects Report #5504715-3
Velcade side effect was reported by a Physician from JAPAN on Oct 19, 2007. Male patient, 67 years of age, weighting 136.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, blood uric acid increased, condition aggravated, disease progression, gastrointestinal haemorrhage, haemorrhagic diathesis, multiple myeloma . Velcade dosage: 2.00 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, BETAMETHASONE, ORGARAN. Patient died on 09/10/2007.

Velcade Side Effects Report #5574020-8
Velcade side effect was reported by a Physician from JAPAN on Dec 11, 2007. Male patient, 67 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , condition aggravated, dementia , disease progression, platelet count decreased, thrombosis. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE. Patient died on 12/09/2007.

Velcade Side Effects Report #5671737-1
Velcade side effect was reported by a Physician from UNITED STATES on Mar 03, 2008. Female patient, 67 years of age, weighting 145.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: atelectasis, back pain , condition aggravated, influenza, oedema peripheral, pneumonia . Velcade dosage: 1.30 MG/M2,INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, SYNTHROID, NEXIUM, TOPROL, BENICAR, ACTONEL, ALLEGREA, ALLEGRA. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5753097-0
Velcade side effect was reported by a Physician from UNITED STATES on May 12, 2008. Male patient, 67 years of age, weighting 209.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal abscess, blood culture positive, bowel preparation, colonic obstruction, colostomy, computerised tomogram normal, condition aggravated, culture wound positive, diverticular perforation. Velcade dosage: 1MG/M2. During the same period patient was treated with DEXAMETHASONE, THALIDOMIDE, MELPHALAN, CISPLATIN, DOXORUBICIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5282597-5
Velcade side effect was reported by a Physician from UNITED STATES on Mar 15, 2007. Male patient, 66 years of age, weighting 226.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain , alveolitis allergic, anaemia of chronic disease, cardiac failure congestive, condition aggravated, diarrhoea, eosinophilic pneumonia, fatigue. Velcade dosage: 1.00 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, DOXIL, ZOLOFT, FAMOTIDINE, ATROVENT HFA, PROCRIT. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5054022-0
Velcade side effect was reported by a Physician from AUSTRALIA on July 05, 2006. Male patient, 66 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bronchiolitis, condition aggravated, herpes zoster, influenza, pneumonia , pneumonitis, pulmonary toxicity, respiratory failure, viral infection . Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE, BACTRIM, NEXIUM, AMITRIPTYLINE, SIMVASTATIN, NYSTATIN, VALCICLOVIR. Patient was hospitalized. Patient died on 06/25/2006.

Velcade Side Effects Report #5578223-8
Velcade side effect was reported by a Physician from JAPAN on Dec 10, 2007. Male patient, 66 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, anorexia, blood alkaline phosphatase increased, blood creatinine increased, blood urea increased, condition aggravated, disease progression, hypotension, nausea . Velcade dosage: 2.20 MG. During the same period patient was treated with ULCERLMIN, DEXAMETHASONE, DIGOXIN, VOLTAREN, MAGNESIUM OXIDE, CYTOTEC, PURSENNID, LANSOPRAZOLE. Patient was hospitalized. Patient died on 06/11/2007.

Velcade Side Effects Report #5268779-7
Velcade side effect was reported by a Physician from JAPAN on Mar 05, 2007. Female patient, 65 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: condition aggravated, haematuria, neoplasm malignant. Velcade dosage: 1.30 MG/M2. During the same period patient was treated with DEXAMETHASONE, MEROPEN, BAKTAR, VORICONAZOLE, MORPHINE, FAMOTIDINE, BENZYLPENICILLIN, RED BLOOD CELLS. Patient died on 02/18/2007.

Velcade Side Effects Report #5327173-0
Velcade side effect was reported by a Physician from UNITED STATES on Apr 30, 2007. Female patient, 65 years of age, weighting 91.05 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain , anxiety , asthenia, asthma , bone pain, cachexia, chronic obstructive pulmonary disease, condition aggravated, constipation . Velcade dosage: 1.30 MG/M2, IV BOLUS. During the same period patient was treated with DEXAMETHASONE, ARANESP, KYTRIL, ATIVAN, FORADIL AEROLIZER, PERCOCET, ZOMETA, MIRALAX. Patient was hospitalized. Patient died on 02/06/2007.


Velcade Side Effects Report #5385944-9
Velcade side effect was reported by a Physician from JAPAN on June 29, 2007. Female patient, 65 years of age, weighting 90.39 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, chest discomfort, chest pain , condition aggravated, constipation , diarrhoea, disease recurrence, electrocardiogram qt prolonged, electrocardiogram st segment elevation. Velcade dosage: 1.60 MG, INTRAVENOUS. During the same period patient was treated with NEUPOGEN, MAXIPIME, CONIEL, ISOSORBIDE DINITRATE, DIFLUCAN, SULFAMETHOXAZOLE, BLOPRESS, FAMOTIDINE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5719033-8
Velcade side effect was reported by a Physician from CROATIA (local name: Hrvatska) on Apr 09, 2008. Female patient, 65 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: condition aggravated, herpes zoster, pneumonia , pseudomembranous colitis, renal impairment. Velcade dosage: unknown. Patient was hospitalized. Patient died on 11/29/2007.

Velcade Side Effects Report #5874849-2
Velcade side effect was reported by a Physician from JAPAN on Aug 22, 2008. Male patient, 65 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, condition aggravated, multiple myeloma , pleural effusion, renal failure, tumour lysis syndrome. Velcade dosage: unknown. Patient recovered.

Velcade Side Effects Report #5921271-6
Velcade side effect was reported by a Physician from JAPAN on Sept 30, 2008. Male patient, 65 years of age, weighting 160.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood chloride increased, blood lactate dehydrogenase, cardiac failure, clavicle fracture, condition aggravated, coronary artery stenosis, diarrhoea, humerus fracture. Velcade dosage: 2.10 MG, INTRAVENOUS; 1.6 MEQ, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, SELBEX, WARFARIN POTASSIUM, BUCOLOME, BISOPROLOL FUMARATE, ALLOPURINOL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #6009123-7
Velcade side effect was reported by a Physician from JAPAN on Dec 02, 2008. Male patient, 65 years of age, weighting 160.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, atrial fibrillation , blood chloride increased, blood lactate dehydrogenase increased, cardiac failure, clavicle fracture, condition aggravated, coronary artery stenosis. Velcade dosage: 2.10 MG, INTRAVENOUS; 1.6 MEQ, INTRAVENOS; 20 MG, ORAL. During the same period patient was treated with DEXAMETHASONE, SELBEX, WARFARIN, PARAMIDIN, BISOPROLOL FUMARATE, ALLOPURINOL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #6039413-3
Velcade side effect was reported by a Physician from JAPAN on Jan 08, 2009. Male patient, 65 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, chest pain , condition aggravated, crystal urine present, disease progression, disorientation, infection , malaise, malignant neoplasm progression. Velcade dosage: 1.3 MG/M2, INTRAVENOUS. During the same period patient was treated with ALGINATE, VOLTAREN, NIZATIDINE, MUCOSTA, URSO, LASIX, IDOMETHINE, XYLOCAINE. Patient died on 01/02/2009.

Velcade Side Effects Report #5811341-5
Velcade side effect was reported by a Physician from JAPAN on July 03, 2008. Male patient, 64 years of age, weighting 134.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: condition aggravated, progressive multifocal leukoencephalopathy. Velcade dosage: unknown. Patient died on 03/01/2008.

Velcade Side Effects Report #5827099-X
Velcade side effect was reported by a Physician from JAPAN on July 09, 2008. Male patient, 64 years of age, weighting 134.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: aortic arteriosclerosis, arteriosclerosis coronary artery, atelectasis, bronchopneumonia, colitis ischaemic, condition aggravated, cytomegalovirus antigen positive, epstein-barr virus antigen positive, extramedullary haemopoiesis. Velcade dosage: 2 MG, INTRAVENOUS. Patient died on 03/01/2008.

Velcade Side Effects Report #5944248-3
Velcade side effect was reported by a Physician from UNITED STATES on Oct 23, 2008. Male patient, 64 years of age, weighting 170.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, condition aggravated, lactobacillus infection, pericardial effusion, pneumonia , staphylococcal infection . Velcade dosage: 1 MG/M2, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, DILAUDID, ACYCLOVIR, POTASSIUM, PREVAICD, COUMADIN, VITAMIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5225692-9
Velcade side effect was reported by a Physician from JAPAN on Jan 16, 2007. Female patient, 63 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, condition aggravated, diarrhoea, ileus, interstitial lung disease, pneumocystis jiroveci pneumonia, pulmonary mycosis. Velcade dosage: 1.40 MG; 1.80 MG. During the same period patient was treated with ITRACONAZOLE, DEXAMETHASONE, MAGNESIUM OXIDE, MALFA. Patient died on 01/10/2007.


Velcade Side Effects Report #5345108-1
Velcade side effect was reported by a Physician from GERMANY on May 22, 2007. Male patient, 63 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: condition aggravated, neuroborreliosis, paraesthesia. Velcade dosage: unknown. Patient recovered.

Velcade Side Effects Report #5495514-X
Velcade side effect was reported by a Physician from JAPAN on Oct 12, 2007. Male patient, 63 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, cardiac failure, cardiac hypertrophy, condition aggravated, diarrhoea, disseminated intravascular coagulation, fungal infection , hypoalbuminaemia, multiple myeloma . Velcade dosage: 2.00 MG,; 1.50 MG,. During the same period patient was treated with DEXAMETHASONE, MUCOSTA, AMPHOTERICIN B, RABEPRAZOLE, ZOLPIDEM TARTRATE, BAKTAR, ITRACONAZOLE. Patient was hospitalized. Patient died on 05/29/2007.

Velcade Side Effects Report #4830363-4
Velcade side effect was reported by a Health Professional from ARGENTINA on Oct 31, 2005. Female patient, 63 years of age, weighting 125.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: condition aggravated, pneumonia , retinal vein thrombosis. Velcade dosage: 1.30 MG/M2, 2/WEEK, INTRAVENOUS. Patient was hospitalized and became disabled. Patient recovered.

Velcade Side Effects Report #5316377-9
Velcade side effect was reported by a Health Professional from UNITED STATES on Apr 17, 2007. Male patient, 62 years of age, weighting 179.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: atelectasis, bronchopulmonary aspergillosis, cholelithiasis, clostridium difficile colitis, condition aggravated, decreased appetite, exfoliative rash, eye discharge, febrile neutropenia. Velcade dosage: 2.35 MG. During the same period patient was treated with THALIDOMIDE, DEXAMETHASONE, CISPLATIN, DOXORUBICIN, CYCLOPHOSPHAMIDE, ETOPOSIDE, VALTREX. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5455054-0
Velcade side effect was reported by a Physician from JAPAN on Sept 03, 2007. Female patient, 62 years of age, weighting 94.80 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood chloride decreased, condition aggravated, diarrhoea, hypoaesthesia, hyponatraemia, platelet count decreased, pyrexia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, OMEPRAL, ITRACONAZOLE, BAKTAR, ALLOPURINOL, PLATELETS. Patient recovered.

Velcade Side Effects Report #5753073-8
Velcade side effect was reported by a Physician from JAPAN on May 14, 2008. Male patient, 62 years of age, weighting 183.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, blood lactate dehydrogenase increased, cardiac failure, cardiomegaly, condition aggravated, disease progression, malaise, multiple myeloma , neutropenia. Velcade dosage: 2 MG, INTRAVENOUS, 1.6 MG, INTRAVENOUS, 1.8 MG, INTRAVENOUS, 2.6 MG, INTRAVENOUS. During the same period patient was treated with ORGADRONE. Patient was hospitalized. Patient died on 04/08/2008.

Velcade Side Effects Report #4836951-3
Velcade side effect was reported by a Physician from MACEDONIA, THE FORMER YUGOSLAV REPUBLIC OF on Nov 04, 2005. Male patient, 62 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anuria, asthenia, blood potassium increased, cardiopulmonary failure, coagulopathy, condition aggravated, dehydration, fatigue, gamma-glutamyltransferase increased. Velcade dosage: 2.50 MG, INTRAVENOUS. Patient was hospitalized and became disabled. Patient died on 10/29/2005.

Velcade Side Effects Report #5741345-2
Velcade side effect was reported by a Physician from JAPAN on May 01, 2008. Female patient, 61 years of age, weighting 110.2 lb, was diagnosed with multiple myeloma , bronchitis  and was treated with Velcade. After drug was administered, patient experienced the following side effects: activities of daily living impaired, anaemia, blood lactate dehydrogenase increased, blood test abnormal, cardiovascular disorder, condition aggravated, deep vein thrombosis , haemoglobin decreased, hyperamylasaemia. Velcade dosage: 1.80 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, PREDNISOLONE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, DIFLUCAN, ALENDRONATE, ALLOPURINOL, SELBEX, NIZATIDINE. Patient recovered.

Velcade Side Effects Report #4716966-6
Velcade side effect was reported by a Health Professional from UNITED STATES on June 29, 2005. Male patient, 61 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, bladder disorder, compression fracture, condition aggravated, delirium, dyspnoea, haematuria, pneumonia , urinary retention. Velcade dosage: unknown. During the same period patient was treated with THALIIDOMIDE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4952195-9
Velcade side effect was reported by a Physician from FRANCE on Mar 02, 2006. Female patient, 61 years of age, weighting 180.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: coma, condition aggravated, intracranial pressure increased, lung disorder, meningitis , multiple myeloma , pneumonia aspiration, somnolence. Velcade dosage: 2.30 MG, SINGLE, INTRATHECAL. During the same period patient was treated with METHOTREXATE, MELPHALAN, HYDROCORTISONE. Patient died on 12/15/2005.

Velcade Side Effects Report #5216785-0
Velcade side effect was reported by a Physician from JAPAN on Jan 12, 2007. Female patient, 60 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: condition aggravated, neutropenia. Velcade dosage: 1.00 MG/M2. Patient died on 01/10/2007.

Velcade Side Effects Report #5217104-6
Velcade side effect was reported by a Physician from GERMANY on Jan 10, 2007. Male patient, 60 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, blood immunoglobulin g increased, blood lactate dehydrogenase increased, condition aggravated, epistaxis, headache , infection , malaise, thrombocytopenia. Velcade dosage: 2.30 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient died on 12/31/2006.

Velcade Side Effects Report #5332052-9
Velcade side effect was reported by a Physician from GERMANY on May 09, 2007. Male patient, 60 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, blood lactate dehydrogenase increased, condition aggravated, epistaxis, headache , infection , malaise, thrombocytopenia, vertigo. Velcade dosage: 2.30 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient died on 12/31/2006.

Velcade Side Effects Report #5474864-7
Velcade side effect was reported by a Physician from JAPAN on Sept 19, 2007. Female patient, 60 years of age, weighting 99.21 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, bone marrow failure, bone neoplasm, condition aggravated, disease progression, dyspnoea, neutropenia, platelet count decreased, pleural effusion. Velcade dosage: 1.40 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, MUCOSTA, TOLEDOMIN, BAKTAR, PURSENNID, LANSOPRAZOLE, FENTANYL, FIRSTCIN. Patient died on 01/10/2007.

Velcade Side Effects Report #5872525-3
Velcade side effect was reported by a Physician from JAPAN on Aug 27, 2008. Female patient, 60 years of age, weighting 110.2 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, condition aggravated, genital herpes, multiple myeloma , urinary retention. Velcade dosage: 1.7 MG, INTRAVENOUS; 1.3 MG, INTRAVENOUS. During the same period patient was treated with MUCOSTA, FAMOTIDINE, LENDORM. Patient died on 08/04/2008.

Velcade Side Effects Report #5893426-0
Velcade side effect was reported by a Physician from JAPAN on Sept 09, 2008. Female patient, 60 years of age, weighting 110.2 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, condition aggravated, genital herpes, multiple myeloma , urinary retention. Velcade dosage: 1.7 MG, INTRAVENOUS, 1.3 MG, INTRAVENOUS. During the same period patient was treated with MUCOSTA, FAMOTIDINE, LENDORMIN. Patient died on 08/04/2008.

Velcade Side Effects Report #5912905-0
Velcade side effect was reported by a Physician from JAPAN on Sept 22, 2008. Female patient, 60 years of age, weighting 94.80 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, coma, condition aggravated, disorientation, fall , genital herpes, hyperproteinaemia, ill-defined disorder, platelet count decreased. Velcade dosage: 1.7 MG, INTRAVENOUS; 1.3 MG, INTRAVENOUS. During the same period patient was treated with MUCOSTA, FAMOTIDINE, LENDORMIN, DEXAMETHASONE PHOSPHATE, ADONA, TRANSAMIN, BICARBONATE. Patient died on 08/04/2008.

Velcade Side Effects Report #5945819-0
Velcade side effect was reported by a Physician from JAPAN on Oct 24, 2008. Female patient, 60 years of age, weighting 94.80 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, coma, condition aggravated, constipation , cystitis, fall , genital abscess, genital herpes, hyperproteinaemia. Velcade dosage: 1.7 MG/M2, INTRAVENOUS; 1.3 MG, INTRAVENOUS. During the same period patient was treated with MUCOSTA, FAMOTIDINE, LENDORMIN, DEXAMETHASONE PHOSPHATE, ADONA, TRANSAMIN, BICARBONATE. Patient died on 08/04/1948.

Velcade Side Effects Report #4871869-1
Velcade side effect was reported by a Physician from FRANCE on Dec 15, 2005. Female patient, 60 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: condition aggravated, intracranial pressure increased. Velcade dosage: unknown. During the same period patient was treated with METHOTREXATE, MELPHALAN, HYDROCORTISONE. Patient died on 12/15/2005.

Velcade Side Effects Report #5458129-5
Velcade side effect was reported by a Physician from JAPAN on Sept 10, 2007. Male patient, 59 years of age, weighting 119.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: condition aggravated, diarrhoea, disease progression, malaise, myelodysplastic syndrome. Velcade dosage: 1.70 MG, INTRAVENOUS; 2.00 MG, INTRAVENOUS; 1.50 MG, INTRAVENOUS; 2.00 MG, INTRAVENOUS. During the same period patient was treated with ITRACONAZOLE, LOPERAMIDE, AMARYL, PELTAZON, ZOLPIDEM TARTRATE. Patient died on 09/01/2007.

Velcade Side Effects Report #5500121-6
Velcade side effect was reported by a Physician from JAPAN on Oct 15, 2007. Male patient, 59 years of age, weighting 130.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, ascites, condition aggravated, haematemesis, haemorrhagic diathesis, hypoalbuminaemia, melaena, neoplasm malignant, neoplasm progression. Velcade dosage: 2.20 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, BAKTAR, BIOFERMIN, PRIMPERAN, LOPERAMIDE, NOVAMIN, BUMINATE. Patient died on 04/21/2007.

Velcade Side Effects Report #5515869-7
Velcade side effect was reported by a Physician from JAPAN on Oct 31, 2007. Female patient, 59 years of age, weighting 123.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bone neoplasm, condition aggravated, disease progression, hepatic function abnormal, hepatic neoplasm, leukaemia, multiple myeloma , platelet count decreased, pleural effusion. Velcade dosage: 2.00 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ALLOPURINOL, ASPIRIN, FAMOTIDINE, METHYCOBAL, MAGNESIUM OXIDE, RED BLOOD CELLS, PLATELETS. Patient was hospitalized. Patient died on 10/03/2007.

Velcade Side Effects Report #5705319-X
Velcade side effect was reported by a Physician from JAPAN on Apr 08, 2008. Female patient, 59 years of age, weighting 110.2 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood pressure decreased, cardiovascular function test abnormal, condition aggravated, dialysis , disease progression, extrapyramidal disorder, fracture , nausea . Velcade dosage: unknown. Patient died on 03/28/2008.

Velcade Side Effects Report #5713111-5
Velcade side effect was reported by a Physician from JAPAN on Apr 09, 2008. Female patient, 59 years of age, weighting 110.2 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: arrhythmia , blood pressure decreased, condition aggravated, dialysis , disease progression, extrapyramidal disorder, multiple fractures, nausea , rib fracture. Velcade dosage: unknown. Patient died on 03/28/2008.